Abstract:Ferroptosis, distinct from apoptosis, necrosis, and autophagy, is a unique type of cell death driven by iron-dependent phospholipid peroxidation. Since ferroptosis was defined in 2012, it has received widespread attention from researchers worldwide. From a biochemical perspective, the regulation of ferroptosis is strongly associated with cellular metabolism, primarily including iron metabolism, lipid metabolism, and redox metabolism. The distinctive regulatory mechanism of ferroptosis holds great potential for overcoming drug resistance—a major challenge in treating cancer. The considerable role of nanobiotechnology in disease treatment has been widely reported, but further and more systematic discussion on how nanobiotechnology enhances the therapeutic efficacy on ferroptosis-associated diseases still needs to be improved. Moreover, while the exciting therapeutic potential of ferroptosis in cancer has been relatively well summarized, its applications in other diseases, such as neurodegenerative diseases, cardiovascular and cerebrovascular diseases, and kidney disease, remain underreported. Consequently, it is necessary to fill these gaps to further complete the applications of nanobiotechnology in ferroptosis. In this review, we provide an extensive introduction to the background of ferroptosis and elaborate its regulatory network. Subsequently, we discuss the various advantages of combining nanobiotechnology with ferroptosis to enhance therapeutic efficacy and reduce the side effects of ferroptosis-associated diseases. Finally, we analyze and discuss the feasibility of nanobiotechnology and ferroptosis in improving clinical treatment outcomes based on clinical needs, as well as the current limitations and future directions of nanobiotechnology in the applications of ferroptosis, which will not only provide significant guidance for the clinical applications of ferroptosis and nanobiotechnology but also accelerate their clinical translations.

Biological protein mediated ferroptotic tumor nanotherapeutics

Bioactive Metal-Containing Nanomaterials for Ferroptotic Cancer Therapy

Targeting Ferroptosis in Breast Cancer

Recent advances of ferroptosis in tumor: From biological function to clinical application

Ferroptosis-Inducing Nanomedicine for Cancer Therapy

Recent research progress based on ferroptosis-related signaling pathways and the tumor microenvironment on it effects

Ferroptosis-based drug delivery system as a new therapeutic opportunity for brain tumors

Recent progress in nanotechnology based ferroptotic therapies for clinical applications

Recent Progress on Nanomedicine-Induced Ferroptosis for Cancer Therapy.

The potential application of nanomaterials for ferroptosis-based cancer therapy

Recent progress in biomaterials-driven ferroptosis for cancer therapy

Self-assembled Nanomaterials for Ferroptosis-Based Cancer Theranostics.

Biomimetic Nanomaterials Triggered Ferroptosis for Cancer Theranostics

Nanobiotechnology boosts ferroptosis: opportunities and challenges

Nanotechnology-integrated Ferroptosis Inducers: A Sharp Sword against Tumor Drug Resistance

Ferroptosis: emerging roles in lung cancer and potential implications in biological compounds

Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges

Nanodrug Delivery Systems for Ferroptosis-Based Cancer Therapy

Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and Nanotechnology

Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications

Ferroptosis and its emerging role in tumor